Clinical Trials Directory

Trials / Completed

CompletedNCT04022746

An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer

Multiparametric MRI and MRE Assessment of Liver Fibrosis in Patients Treated for HCC

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This trial studies how well an investigational scan (magnetic resonance elastography \[MRE\]) works with standard imaging (magnetic resonance imaging \[MRI\]) in detecting response to treatment in patients with liver cancer that has spread to other places in the body. Diagnostic procedures, such as MRE with MRI, may make it easier for researchers to see if the treatment for liver cancer is working.

Detailed description

PRIMARY OBJECTIVE: I. To evaluate the ability of magnetic resonance (MR) elastography (MRE) to detect changes in hepatocellular carcinoma (HCC) between baseline and after initial 6 weeks of treatment (change in MRE liver tumor stiffness compared to percent non-viable/necrotic tumor). SECONDARY OBJECTIVES: I. Correlate MRE imaging measurements with patient survival (overall survival and time to tumor progression) over 18 months. II. Correlate MRE measurements with change in tumor size and enhancement on standard of care MR imaging sequences. OUTLINE: Patients undergo standard of care MRI and MRE over 30-90 minutes within 5 days of liver biopsy before receiving any medical treatment for HCC, at 6 weeks after medical treatment for HCC, and then every 12 weeks for up to 24 months.

Conditions

Interventions

TypeNameDescription
PROCEDUREMagnetic Resonance ElastographyUndergo multiparametric MRI/MRE
PROCEDUREMagnetic Resonance ImagingUndergo multiparametric MRI/MRE

Timeline

Start date
2019-06-11
Primary completion
2025-02-13
Completion
2025-02-13
First posted
2019-07-17
Last updated
2025-02-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04022746. Inclusion in this directory is not an endorsement.